This study investigated MOTS-c's effects on cells harboring the 3243 A-to-G mitochondrial DNA mutation, which causes mitochondrial disease. The researchers examined whether MOTS-c could improve mitochondrial function in these mutant cells, exploring the peptide's potential as a therapeutic agent for mitochondrial disorders.
Ahn, Chang Ho; Choi, Eun Hye; Kong, Byung Soo; Cho, Young Min